279 related articles for article (PubMed ID: 18841291)
1. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.
Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H
Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates.
Cauwenberghs N; Meiring M; Vauterin S; van Wyk V; Lamprecht S; Roodt JP; Novák L; Harsfalvi J; Deckmyn H; Kotzé HF
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1347-53. PubMed ID: 10807753
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
4. Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4.
Fontayne A; Vanhoorelbeke K; Pareyn I; Van Rompaey I; Meiring M; Lamprecht S; Roodt J; Desmet J; Deckmyn H
Thromb Haemost; 2006 Nov; 96(5):671-84. PubMed ID: 17080226
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons.
Wu D; Meiring M; Kotze HF; Deckmyn H; Cauwenberghs N
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):323-8. PubMed ID: 11834536
[TBL] [Abstract][Full Text] [Related]
6. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
[TBL] [Abstract][Full Text] [Related]
7. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
9. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
10. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries.
Azzam K; Garfinkel LI; Bal dit Sollier C; Cisse Thiam M; Drouet L
Thromb Haemost; 1995 Feb; 73(2):318-23. PubMed ID: 7792749
[TBL] [Abstract][Full Text] [Related]
12. Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment.
Yang J; Ji S; Dong N; Zhao Y; Ruan C
Hybridoma (Larchmt); 2010 Apr; 29(2):125-32. PubMed ID: 20443704
[TBL] [Abstract][Full Text] [Related]
13. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
14. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
[TBL] [Abstract][Full Text] [Related]
15. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
Deckmyn H; Cauwenberghs N; Wu D; Depraetere H; Vanhoorelbeke K
Verh K Acad Geneeskd Belg; 2005; 67(1):55-65. PubMed ID: 15828307
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig].
Cissé-Thiam M; Girma JP; Meyer D; Drouet L
Dakar Med; 1999; 44(1):45-8. PubMed ID: 10797986
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
18. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys.
Kageyama S; Yamamoto H; Nakazawa H; Matsushita J; Kouyama T; Gonsho A; Ikeda Y; Yoshimoto R
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):187-92. PubMed ID: 11788481
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
